- Enrollment Event Date
- Informed Consent
- Enrollment and Randomization
- Recipient Inclusion Exclusion Criteria Not Met
- Donor Inclusion Exclusion Criteria
- Demographics
- Screening Event Date
- Physical Examination & Vital Signs
- Recipient CMV Serostatus
- Recipient ABO/Rh Typing
- Recipient HLA Typing
- HCT-CI Score
- Echocardiogram or MUGA
- Pulmonary Evaluation
- Renal Assessment – CrCl
- Performance Status
- Pregnancy Test
- Hematology Lab Panel – CBC
- Blood Chemistry Lab Panel
- Recipient Disease
- ALL Pre-HCT Disease Evaluation
- AML Pre-HCT Disease Evaluation
- Other Acute Leukemia Pre-HCT Disease Evaluation
- MDS Pre-HCT Disease Evaluation
- MDS/MPN Pre-HCT Disease Evaluation
- MPN Pre-HCT Disease Evaluation
- CLL and Other Leukemia Pre-HCT Disease Evaluation
- Lymphoma Pre-HCT Disease Evaluation
- Pre-HCT Bone Marrow Assessment
- Pre-HCT Flow Cytometry
- Pre-HCT Cerebrospinal Fluid (CSF) Evaluation
- Pre-HCT Measurable Residual Disease Assessment
- Conditioning Event Date
- Pre- Conditioning Infection Assessment
- Conditioning Regimen
- Conditioning Regimen Details
- Research Sample Collection – Stool
- Day 0 Event Date
- Infusion
- Research Sample Collection – PBSC
- Post-Transplant Cyclophosphamide
- Mycophenolate Mofetil (MMF) Administration
- Tacrolimus Administration
- Abatacept Administration
- Ruxolitinib Administration
- Follow-Up Day 7 and 14
- Follow-Up Day 28, 56, 100, 180
- Follow-Up Day 270 Day 365
- Infection
- Acute GVHD
- Cytokine Release Syndrome
- Research Sample Collection – Blood
- Research Sample Collection – Relapse
- Growth Factors
- Chimerism Evaluation
- Primary Graft Failure
- Relapse / Progression
- Hematopoietic Recovery
- Chronic or Overlap GVHD
- Day 365 Bone Marrow Assessment
- Day 365 Imaging
- Medical History
- Concomitant Medications
- Adverse Events Reporting
- Adverse Events
- Protocol Deviation
- Unanticipated Problem
- Re-Consent
- Off Protocol
- Study Exit / Study Completion
- Death Data
CCG Updates:
Sections of the ACCELERATE CRF Completion Guidelines may occasionally be updated. In addition to documenting the changes within each section, a summary of the most recent updates to the guidelines can be found below. For additional information, select the section and review the updated text.
Date | Guidelines Section | Add/Remove/Modify | Description |
---|---|---|---|
N/A | N/A | N/A | N/A |
CCG v1.0 | CRF v1.3
Post your comment on this topic.